Wells Fargo Analyst Sees Potential in Argenx SE’s (ARGX) Vyvgart, Increases PT to $1,317

Core Viewpoint - Argenx SE (NASDAQ:ARGX) is highlighted as one of the best stocks to buy, with a price target increase from Wells Fargo reflecting strong growth potential in its product Vyvgart [1][2]. Group 1: Price Target and Analyst Outlook - Wells Fargo raised the price target on Argenx SE from $1,264 to $1,317, maintaining an Overweight rating on the shares [1][2]. - Analyst Derek Archila increased the 2026-2030 outlook for Vyvgart by 5-15%, indicating confidence in the product's performance [2]. - The consensus estimate for Argenx's FY2026 revenue is projected at $5.6 billion, but Archila anticipates it will reach approximately $6.5 billion, driven by growth in subsequent quarters [3]. Group 2: Stock Performance and Analyst Sentiment - Over the past six months, Argenx SE's shares have increased by over 45% as of January 27 [4]. - Among 28 analysts covering ARGX, 86% have rated the stock as a Buy, with a median price target of $1,007.86, suggesting a potential upside of 16.80% [4].